Paediatric malaria in Greece in the era of global population mobility

Helena C Maltezou1, Maria Tsolia, Ioannis Polymerou

  • 1Department for Interventions in Health-Care Facilities, Hellenic Center for Disease Control and Prevention, 3-5 Agrafon Street, Athens, Greece. helen-maltezou@ath.forthnet.gr

Insights

Paediatric malaria cases in Greece significantly increased between 2003-2012, primarily affecting children who traveled to malaria-endemic regions. This rise is linked to immigration and visits by friends and relatives (VFRs).

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Malaria poses a significant public health concern globally.
  • Understanding the epidemiological trends of pediatric malaria is crucial for effective control strategies.

Purpose of the Study:

  • To analyze the epidemiological shift of pediatric malaria cases in Greece.
  • To identify the primary risk factors and travel patterns associated with pediatric malaria in Greece.

Main Methods:

  • Retrospective review of medical records of children admitted with malaria.
  • Data collection from four tertiary-care hospitals in Greece spanning 1972-2012.
  • Analysis of patient demographics, travel history, and symptom onset.

Main Results:

  • A total of 21 pediatric malaria cases were identified, with a notable increase (20 cases) observed between 2003 and 2012.
  • Over 76% of affected children had traveled to malaria-endemic countries within 50 days prior to symptom onset.
  • Immigration and travel by friends and relatives (VFRs) were the predominant reasons for travel.

Conclusions:

  • A significant epidemiological shift in pediatric malaria has occurred in Greece over the past decade.
  • The increase is predominantly attributed to a rise in immigrant populations and VFR travelers.
  • Public health initiatives should focus on risk assessment and prevention strategies for these demographic groups.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...